Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor Under Steady State Conditions in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2014
At a glance
- Drugs Dabigatran etexilate (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes; Peripheral arterial disorders; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Apr 2013 Planned end date changed from 1 Apr 2013 to 1 May 2013 as reported by ClinicalTrials.gov.